This announcement is a separate document:
康弘药业：2023年股票增值权激励计划（草案）摘要
Kanghong Pharmaceutical: Summary of the 2023 Stock Value-Added Rights Incentive Plan (Draft)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.